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Letter to the Editor 
Sir, 
      An interesting report is presented by de Bot et al. (2012) (4) on a rare type 8 autosomal-
dominant form of hereditary spastic paraplegia (HSP) caused by a mutation in the VCP gene. 
Here we present, for the first time we believe, the neuropathological findings in an HSP type 
8 (SPG8) case with a confirmed KIAA0196 mutation. 
      HSP is clinically and genetically a heterogeneous group of disorders with more than 72 
loci and 55 genes known to be involved so far (12). SPG8 has been described in 13 families 
(2, 5, 8, 10) and presents as a pure spastic paraplegia without associated neurological 
abnormalities in all families but one (2). SPG8 is caused by mutations in the strumpellin gene 
KIAA0196. Eleven different missense mutations (2, 5, 10) and one large deletion in intron 10 
– exon 15 of KIAA0196 (10) have been identified so far in patients with SPG8 
(www.hgmd.cf.ac.uk). Strumpellin knockdown experiments in human neuroblastoma cells 
demonstrated reduced axonal outgrowth, and knockdown studies in zebrafish revealed severe 
contractile cardiac dysfunction, tail curvature, and impaired motility, implying a strumpellin 
loss-of-function pathogenesis of SPG8 (3). 
      The major neuropathological finding in pure HSP is axonal degeneration, maximal in the 
terminal portions of the longest descending and ascending tracts (1). A case-control study 
quantifying corticospinal tract axon number showed reduced cross-sectional area and axonal 
density in the corticospinal tracts with a more pronounced axonal loss in the distal neuraxis in 
HSP patients. The cross-sectional area and axonal density of the sensory tracts were reduced 
only in the upper regions of the spinal cord. This is consistent with a “dying back” axonal 
degeneration (6). 
      The proband presented here is a 46-year-old male with a slowly progressing spastic 
paraplegia. He was healthy until the age of 37, where he had onset of pain in the lower limbs, 
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intermittent dropfoot, foot clonus, and slight ataxia. At age 45 he had an unaided walking 
distance of 200 m, spasticity and exaggerated deep tendon reflexes in the lower limbs, foot 
clonus and slight paresis of the hip corresponding to an estimated Spastic Paraplegia Rating 
Scale (SPRS) score of 19. He had no symptoms from the bladder, and no cognitive or 
psychiatric symptoms. MRI of the brain and spinal cord was normal. 
      The proband’s mother was healthy until her first pregnancy at 25 years of age, where she 
exhibited slight paresis and spasticity of the legs. A neurological examination at age 34 
revealed slight eye movement ataxia, ataxia of the legs, and exaggerated patellar and heel 
tendon reflexes corresponding to an estimated SPRS score of 15. She was suspected of 
having multiple sclerosis, but the diagnosis was never confirmed. She was re-evaluated at age 
42 due to urine incontinence and progression of the spastic paraparesis – signs and symptoms 
corresponding to an estimated SPRS score of 20. At the age of 61 she suffered from severe 
depression and complained of cognitive deficits. Her unaided walking distance was 25 m 
(estimated SPRS score 25). She died 70 years old following a hemicolectomy due to stage T3 
colon cancer. Her medical history also included surgical treatment and radiotherapy for 
advanced breast cancer, hyperthyroidism, and atrial fibrillation. An autopsy was performed to 
determine the cause of the patient’s symptoms. Informed consent for performing the autopsy 
and related analyses as well to publish this article was obtained from the son of the deceased 
woman. 
      There are no other known affected family members. A 43-year-old brother of the proband 
has no symptoms of spastic paraplegia. The maternal grandfather died suddenly and 
unexpectedly 65 years old and the maternal grandmother had unconfirmed Parkinson’s 
disease and died 89 years old. 
      Mutational analysis of genomic DNA from a peripheral blood sample from the proband 
revealed a missense mutation in the gene for strumpellin (KIAA0196) in exon 16: 
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c.1876G>T; p.(Val626Phe) previously found to be heterozygously present in a British family 
and three large North American families with European ancestry thus confirming the clinical 
diagnosis of SPG8. The presence of the KIAA0196 mutation in the proband’s deceased 
mother was confirmed on DNA extracted from frozen normal colon tissue. The mutation was 
absent in DNA extracted from peripheral blood from the proband’s younger brother.  
      The weight of the fixated brain was 1002 grams. The gross external appearance of the 
brain was normal and there were no signs of atrophy. Sections from the cerebrum, 
cerebellum, pons, mesencephalon and medulla oblongata appeared normal, without signs of 
atrophy, which was confirmed by histological examination. The spinal cord was 39 cm long. 
There was severe atrophy of the spinal cord between the cervical and lumbar enlargements, 
where the spinal cord consisted mainly of vessels and meninges (Fig. 1). Humped surfaces 
were found corresponding to the cervical enlargement and more widespread above, at, and 
below the lumbar enlargement. Grey matter was not readily distinguished on gross horizontal 
sections of the spinal cord in these areas. Cross sections of longitudinal vessels were present.  
Histological examination confirmed severe atrophy of the thoracic spinal cord with 
demyelination as demonstrated by luxol fast blue staining and loss of neurons. Although the 
overall number of motor neurons was preserved in the cervical and lumbar enlargements, 
what appeared to be remnants of motor neurons were found suggesting motor neuron 
degeneration in these spinal cord regions. Moreover the number of axons in the white matter 
was markedly reduced in these parts of the spinal cord. There was no increased number of 
inflammatory cells and no reactive gliosis (Fig. 2). 
      The early reports on the neuropathological changes in HSP were published before the 
genetic background of the HSP subtypes was known. With increasing knowledge of the 
molecular basis of HSP it is possible to relate the neuropathological findings for the different 
subtypes of HSP to the function of the proteins encoded by the corresponding genes. Caution 
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is necessary, however, as HSP often does not shorten lifespan, and neuropathological 
observations may be associated with age or age-associated diseases (7). 
We found pronounced atrophy of the spinal cord, with only remnants of nervous tissue 
between the two enlargements in post mortem tissue from a woman with a confirmed 
mutation in KIAA0196. To our knowledge such severe atrophy has not previously been 
reported in HSP. Spinal cord atrophy is commonly found in SPG8 as well as in other types of 
SPG. SPG6 and SPG8 appear to have particularly severe spinal cord atrophy. A study using 
magnetic resonance imaging found a significantly higher degree of cord atrophy in SPG6 and 
8 compared to SPG3A and 4 (9). Although a neuropathological study found no correlation 
between cross-sectional area and axonal loss in HSP of unknown genetic type (6), our 
findings do indeed indicate a high degree of spinal cord atrophy in SPG8. An autopsy case of 
HSP with thin corpus callosum had severe degeneration in the lateral and anterior 
corticospinal tracts, spinocerebellar tracts and posterior column as reported in a case study by 
Kuru et al. (2005). This was, however, not an HSP8 case, but a complicated type of HSP that 
was not subtyped (11). Another autopsy case compatible with a complicated form of 
autosomal recessive HSP, but not further subtyped, had severe atrophy of the ventral and 
lateral corticospinal tracts in the spinal cord (13). 
From the SPG8 case presented here by us it appears that the almost complete atrophy of 
spinal cord nervous tissue, would be a characteristic neuropathological finding of HSP type 8. 
 
Figure legends 
Figure 1 
      Macroscopic appearance of the spinal cord. a) Spinal cord with severe atrophy. b) The 
portion between the cervical and lumbar enlargements consists mainly of meninges and 
vessels. c) Cervical enlargement. d) Lumbar enlargement. 
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Figure 2 
      Histological appearance of the medulla oblongata and spinal cord. a) Medulla 
oblongata. b-c) Cervical enlargement with reduction in number of axons as demonstrated at 
high magnification of a luxol fast blue stained slide (insert f). d) Severely atrophied spinal 
cord between the cervical and lumbar enlargements with marked reduction in number of 
axons. e) Lumbar enlargement with disorganized overall histology and reduction in number 
of axons demonstrated at high magnification of a luxol fast blue stained slide (insert g). Bars: 
a, b – 5mm; c-e – 2.5mm; f, g – 250µm 
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Macroscopic appearance of the spinal cord. a) Spinal cord with severe atrophy. b) The portion between the 
cervical and lumbar enlargements consists mainly of meninges and vessels. c) Cervical enlargement. d) 
Lumbar enlargement.  
Fig. 1  
63x44mm (300 x 300 DPI)  
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Histological appearance of the medulla oblongata and spinal cord. a) Medulla oblongata. b-c) Cervical 
enlargement with reduction in number of axons as demonstrated at high magnification of a luxol fast blue 
stained slide (insert f). d) Severely atrophied spinal cord between the cervical and lumbar enlargements with 
marked reduction in number of axons. e) Lumbar enlargement with disorganized overall histology and 
reduction in number of axons demonstrated at high magnification of a luxol fast blue stained slide (insert g). 
Bars: a, b – 5mm; c-e – 2.5mm; f, g – 250µm  
Fig. 2  
173x177mm (300 x 300 DPI)  
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